Federal Supply Schedule 36F79723D025E
Award Date
2/15/23
Last Date to Order
5/15/23
Federal Agency
Veterans Integrated Service Network 12
Awardee
TG Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule (FSS) contract awarded to TG Therapeutics Inc. by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 12, covers the procurement of pharmaceuticals, hematology-related products, and other drugs under GSA Schedule 65 IB. The $250,000 multiple award IDV has a period of performance through May 2028, enabling TG Therapeutics to fulfill orders for these medical commodities to treat veterans across VISN 12 facilities. This is the third FSS...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to TG Therapeutics Inc. The contract provides pharmaceuticals and drugs under GSA Schedule 65 IB, which covers drugs, pharmaceuticals, and hematology related products. With a potential value of $20 million and a period of performance through August 2026, this multiple-award contract aims to procure these medical supplies for VA healthcare...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract (36F79722D0202) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 12 to CTI Biopharma Corp. (doing business as CTI Biopharma), a for-profit manufacturer of drugs, pharmaceuticals, and hematology-related products. The multiple-award contract has a ceiling value of $3,000,000 and an ultimate completion date of October 31, 2027. This FSS contract under...
This federal contract IDV is a multiple award Federal Supply Schedule (FSS) contract held by 60 Degrees Pharmaceuticals, Inc. to provide pharmaceutical and hematology products to the U.S. Department of Veterans Affairs (VA) under GSA Schedule 65IB. The contract has a 5-year period of performance and a $250,000 ceiling value, enabling VA medical centers in VISN 12 to procure hematology supplies without separate solicitations. 60 Degrees Pharmaceuticals also holds a separate $25,000 interim FSS...
This federal contract IDV award is for a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, held by Pharmacyclics LLC, an AbbVie company. The contract has a ceiling value of $761,600,000 and a period of performance through August 28, 2025. The contract vehicle is intended to provide the Department of Veterans Affairs and its Veterans Integrated Service Network 12 with a diverse selection of drugs, pharmaceuticals, and hematology-related products....
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Therapeuticsmd, Inc. for the provision of pharmaceuticals, drugs, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. This multiple-award contract has a potential value of $250,000.00 and a period of performance from May 15, 2020 to May 15, 2024. Therapeuticsmd, Inc.,...
This is a multiple award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Invivyd, Inc. for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through November 14, 2024. As a Federal Supply Schedule contract, this agreement provides a streamlined procurement vehicle for federal agencies to acquire the covered pharmaceutical and...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to SK Life Science, Inc., a subsidiary of SK Inc. The contract, with a ceiling value of $700,000.00, is under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and has an ultimate completion date of October 31, 2025. The contract aims to provide the VA with a wide range of pharmaceutical and hematology-related products. As an FSS contract, it allows for the...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to LXO US, Inc., a small disadvantaged business. The contract, with a ceiling value of $1,134,150.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Contract 65 I B. The period of performance is from May 15, 2025, to May 14, 2030. As a multiple-award FSS contract, this vehicle allows the VA and other federal agencies to...